Claris Lifesciences Said Talking Sale Of Injectables To Otsuka Pharma
This article was originally published in PharmAsia News
Executive Summary
Claris Lifesciences reportedly is discussing to sell its injectables business, which generate more than half of the India-based firm's revenues, to be Otsuka Pharma.